Author contributions
XS designed and supervised the clinical study; HW and XD supervised the CAR T-cell production; XS conducted preclinical validation and quality control; JN, HQ, and FX collected clinical data; JN, FX, LZ, HQ, JY, CH, KZ, YT, YC, BD, YL, XS, LW, XD, HW, XS enrolled patients and took care of the patients; JN contributed to response monitoring of the patients.